These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22920015)

  • 1. Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice.
    Kes P; Basić-Kes V; Basić-Jukić N; Demarin V
    Acta Clin Croat; 2012 Mar; 51(1):137-53. PubMed ID: 22920015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic indications for therapeutic plasma exchange: 2011 update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2012; 27(3):138-45. PubMed ID: 22522566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurologic indications for therapeutic plasma exchange: 2013 update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2014 Aug; 29(4):211-9. PubMed ID: 24890467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders.
    Lehmann HC; Hartung HP; Hetzel GR; Stüve O; Kieseier BC
    Arch Neurol; 2006 Jul; 63(7):930-5. PubMed ID: 16831960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurologic indications for therapeutic plasma exchange: an update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2011; 26(5):261-8. PubMed ID: 21915895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic plasma exchange in neurologic disorders.
    Kes P
    Acta Med Croatica; 1997; 51(4-5):225-8. PubMed ID: 9473803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases.
    Yücesan C; Arslan O; Arat M; Yücemen N; Ayyildiz E; Ilhan O; Mutluer N
    Transfus Apher Sci; 2007 Feb; 36(1):103-7. PubMed ID: 17224307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
    Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
    Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders.
    Lehmann HC; Hartung HP; Hetzel GR; Stüve O; Kieseier BC
    Arch Neurol; 2006 Aug; 63(8):1066-71. PubMed ID: 16908731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis.
    Kaya E; Keklik M; Sencan M; Yilmaz M; Keskin A; Kiki I; Erkurt MA; Sivgin S; Korkmaz S; Okan V; Doğu MH; Unal A; Cetin M; Altuntaş F; Ilhan O
    Transfus Apher Sci; 2013 Jun; 48(3):349-52. PubMed ID: 23619327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intravenous immunoglobulin and plasma exchange in neurological disease.
    Linker RA; Gold R
    Curr Opin Neurol; 2008 Jun; 21(3):358-65. PubMed ID: 18451723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based review of therapeutic plasma exchange in neurological disorders.
    Chhibber V; Weinstein R
    Semin Dial; 2012; 25(2):132-9. PubMed ID: 22277020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoadsorption and plasma exchange-Efficient treatment options for neurological autoimmune diseases.
    Boedecker SC; Luessi F; Engel S; Kraus D; Klimpke P; Holtz S; Meinek M; Marczynski P; Weinmann A; Weinmann-Menke J
    J Clin Apher; 2022 Feb; 37(1):70-81. PubMed ID: 34904748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic plasma exchange in treatment of neuroimmunologic disorders: review of 92 cases.
    Sorgun MH; Erdogan S; Bay M; Ayyıldız E; Yücemen N; Iihan O; Yücesan C
    Transfus Apher Sci; 2013 Oct; 49(2):174-80. PubMed ID: 23820431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic apheresis in neurology critical care.
    Natarajan N; Weinstein R
    J Intensive Care Med; 2005; 20(4):212-25. PubMed ID: 16061904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines on the use of intravenous immune globulin for neurologic conditions.
    Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
    Dalakas MC
    JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases].
    Molnár MJ
    Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
    Dalakas MC
    Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases.
    Tombak A; Uçar MA; Akdeniz A; Yilmaz A; Kaleagası H; Sungur MA; Tiftik EN
    Indian J Hematol Blood Transfus; 2017 Mar; 33(1):97-105. PubMed ID: 28194064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.